Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Newcastle Position Emission Tomography Centre installs new PET-CT scanner

Siemens Healthcare UK : 10 September, 2008  (Application Story)
A Biograph 40 TruePoint PET-CT scanner from Siemens Healthcare has been installed by Newcastle University.
Primarily funded by the regional development agency ONE NorthEast and located at the Newcastle Position Emission Tomography Centre, the system has begun its first clinical trials.

The Biograph 40 TruePoint PET-CT is designed to determine the exact location, size, nature and extent of disease by combining the functional information of PET with the anatomical information acquired by the integrated diagnostic 40-slice CT. The combination of both PET and CT will allow researchers at the university to detect changes in molecular activity, revealing the smallest lesions in fine detail in order to study the nature of cancers.

Researchers at the centre will also focus on Radiotherapy planning and have already begun scans in this area. Hybrid functional and anatomical information from the Biograph 40 will create clear images that reveal the nature of disease. The research team will then use these images to evaluate the efficacy of PET-CT for implementing radiation therapy treatment plans.

“We are very pleased with the image quality of the Biograph 40,” said Dr Ross Maxwell, scientific director of PET-CT at the Newcastle Position Emission Tomography Centre. “Beginning with trials into diagnostic oncology, we hope to make full use of the system’s innovative capabilities by carrying out studies into the evaluation of new cancer drugs, Radiotherapy planning and age-related disorders.”

“The Biograph 40 will allow the research team to expand the use of molecular imaging beyond diagnostics to play a larger role in disease management,” said Lawrence Foulsham, product manager for molecular imaging and oncology at Siemens Healthcare. “These exciting clinical trials into the nature of oncology highlight the potential of PET-CT for treatment planning, therapy monitoring and follow-up. We look forward to seeing how this research progresses and the benefits the Biograph 40 will bring to the centre.”
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo